COMMUNIQUÉS West-GlobeNewswire

Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017

31/10/2017 - 07:00

ALLSCHWIL/BASEL, SWITZERLAND - October 31, 2017 - By decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all publicly held registered shares of Actelion Ltd ( Actelion ) with [...]

TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure

31/10/2017 - 07:00

PRESS RELEASE TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure Leuven (BELGIUM) - October 31, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced [...]

ABLYNX CLOSES ON UNDERWRITERS' OPTION TO PURCHASE $30 MILLION OF ADDITIONAL SHARES IN THE U.S. INITIAL PUBLIC OFFERING

30/10/2017 - 21:30

REGULATED INFORMATION GHENT, Belgium, 30 October 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] , a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody® platform to develop treatments [...]

Nightstar Therapeutics to Participate in Multiple Conferences in November

30/10/2017 - 21:05

LEXINGTON, Mass. and LONDON, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]

Diaxonhit : Résultats semestriels 2017, Bénéfices très positifs de l'acquisition de Capforce Plus

30/10/2017 - 19:02

DIAXONHIT - Résultats semestriels 2017 Premiers bénéfices très positifs de l'acquisition de Capforce Plus Réussite de la première phase d'intégration Accélération de la dynamique commerciale Objectifs opérationnels [...]

Exercise of over-allotment option in relation to the IPO of Terveystalo Plc and termination of the stabilization period

30/10/2017 - 18:00

TERVEYSTALO PLC STOCK EXCHANGE RELEASE 30 October, 2017 at 19:00 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]

NANOBIOTIX lance une augmentation de capital par construction accelerée d'un livre d'ordre

30/10/2017 - 17:47

NANOBIOTIX LANCE UNE AUGMENTATION DE CAPITAL PAR CONSTRUCTION ACCELEREE D'UN LIVRE D'ORDRE Paris, France, et Cambridge, Massachusetts, USA, 30 octobre 2017 - NANOBIOTIX (la « Société ») (Euronext: NANO - ISIN: [...]

NANOBIOTIX launches capital increase by means of an accelerated bookbuild offering

30/10/2017 - 17:47

NANOBIOTIX LAUNCHES CAPITAL INCREASE BY MEANS OF AN ACCELERATED BOOKBUILD OFFERING Paris, France and Cambridge, Massachusetts, October 30, 2017 - NANOBIOTIX (the " Company ") (Euronext: NANO - ISIN: FR0011341205), a [...]

Ascom wins order to supply advanced nurse call solution for elderly care facilities in Norway

30/10/2017 - 17:30

BAAR, Switzerland, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW) secures a long term contract with the Drammen municipality in Norway to modernize and improve the communication infrastructure of its elderly care [...]

Ossur Hf : Transactions in relation to share buyback program

30/10/2017 - 17:00

Announcement from Össur hf. No. 79/2017 Reykjavík, 30 October 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Ossur Hf: Insider trading

30/10/2017 - 15:26

Announcement Össur hf. N o. 78/2017 Viðskipti með eigin bréf/ transaction in own financial instruments Nafn/Name: Össur hf. Dagsetning viðskipta/Date of transaction: 30 October 2017 Kaup eða sala/Buy or Sell: Sell [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

30/10/2017 - 15:00

FIT Biotech Oy Company release October 30, 2017 at 4:00 pm FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On September 26, 2016, the Board of Directors of FIT Biotech Oy ( [...]

Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months

30/10/2017 - 14:45

Company Has Initiated Pivotal Trial for the MobiusHD in the US and EU MOUNTAIN VIEW, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., a privately held medical device company developing novel solutions [...]

RAMSAY GENERALE DE SANTE : Mise à disposition du Document de référence 2017

30/10/2017 - 14:30

Mise à disposition du document de référence au 30 juin 2017 Ramsay Générale de Santé annonce le dépôt de son document de référence au 30 juin 2017 auprès de l'Autorité des Marchés Financiers (AMF) le 27 octobre 2017 [...]

Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

30/10/2017 - 13:30

Management to host conference call WALTHAM, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat [...]

Advanced Bifurcation Systems Announces Appointment of Chief Financial Officer

30/10/2017 - 13:01

LOS ANGELES, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of [...]

Alpha Tau Medical Initiates First Clinical Trial in Italy to Treat Cancer with Alpha Radiation

30/10/2017 - 12:30

TEL AVIV, Israel, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alpha Tau Medical is happy to announce its first clinical trial in Italy. The study at IRST , Meldola, will evaluate the feasibility, safety and efficacy of Alpha DaRT [...]

ERRATUM: NEOVACS : RÉSULTATS SEMESTRIELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES

30/10/2017 - 11:00

Correction du communiqué 17:45 27.10.2017 CEST. Explication de la modification: La date de diffusion des données de preuve de concept préclinique dans le diabète de type 1 reste inchangée par rapport aux annonces [...]

ERRATUM: NEOVACS PROVIDES BUSINESS UPDATE AND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS

30/10/2017 - 11:00

This is a correction of the announcement from 17:45 27.10.2017 CEST. Reason for the correction:the release date of the data for Type 1 Diabete preclicical proof of concept remains unchanged compared to previous [...]